Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory bench research using mouse and human cell lines without human subjects
PubMed 39621724 · doi:10.1080/17590914.2024.2422268
What was done
Researchers investigated the metabolic pathways sustaining energy in mouse (VM-M3, CT-2A) and human (U-87MG) malignant glioma cell lines differing in genetic background and species. Using luciferin-luciferase bioluminescence assays, they measured ATP content and cell viability under varied availability of amino acids, glucose, and oxygen. Oxygen consumption was tracked with the Resipher system, and extracellular lactate and succinate levels were quantified as markers of glycolysis and glutaminolysis, respectively. The study also tested mitochondrial complex IV inhibition and the glutaminase inhibitor 6-diazo-5-oxo-L-norleucine (DON).
What was found
The abstract reports directional findings without specific numerical data or effect sizes. Glutamine maintained ATP content and viability across cell lines independently of oxygen, and no other tested amino acid substituted for it. ATP content persisted under hypoxia and glucose deprivation. Inhibition of mitochondrial complex IV showed that oxygen consumption did not accurately track ATP production via oxidative phosphorylation. DON treatment decreased ATP content and succinate export in glutamine-grown cells, pointing to glutamine-driven mitochondrial substrate-level phosphorylation.
Why it matters
This study proposes that malignant glioma cells rely fundamentally on aerobic fermentation of glucose and glutamine to sustain ATP, with oxidative phosphorylation being neither necessary nor sufficient. This metabolic model highlights glutaminolysis and glycolysis as key therapeutic targets.
Limits
The study is restricted to in vitro cultures across only three cell lines (two mouse, one human) and lacks in vivo validation in animal tumor models or human patients. The abstract provides no exact quantitative metrics, sample replicate numbers, effect sizes, or statistical confidence intervals.
Cited by
- supports Cancer cells drive dysregulated growth through the fermentation of glutamine via substrate-level phosphorylation in the mitochondrial matrix.